iSAM Funds (UK)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
iSAM Funds (UK)'s BMY Position: Q1 2026 in Review
iSAM Funds (UK) sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 42,062 shares — an estimated $2.27M sold.
iSAM Funds (UK) first reported a position in BMY in Q4 2022 and held it in 6 quarters. The position peaked at $2.36M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- iSAM Funds (UK) reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- iSAM Funds (UK) sold 42,062 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.27M.
- iSAM Funds (UK) first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 6 quarters.
- iSAM Funds (UK)'s Bristol-Myers Squibb position peaked at $2.36M in Q3 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on iSAM Funds (UK)'s 13F filing for Q1 2026, filed 13 May 2026.